Clinical Trial Update: The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study) [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating Niacin's effects on HDL and endothelial function in metabolic syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Hannover Medical School | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED